ATE8897T1 - Recognine, ihre chemoreziprokale, am target haftende globuline und verfahren zur herstellung dieser produkte; verfahren zum bestimmen von krebstumoren. - Google Patents

Recognine, ihre chemoreziprokale, am target haftende globuline und verfahren zur herstellung dieser produkte; verfahren zum bestimmen von krebstumoren.

Info

Publication number
ATE8897T1
ATE8897T1 AT80300692T AT80300692T ATE8897T1 AT E8897 T1 ATE8897 T1 AT E8897T1 AT 80300692 T AT80300692 T AT 80300692T AT 80300692 T AT80300692 T AT 80300692T AT E8897 T1 ATE8897 T1 AT E8897T1
Authority
AT
Austria
Prior art keywords
recognin
recognine
chemoreziprocals
globulins
adhesive
Prior art date
Application number
AT80300692T
Other languages
German (de)
English (en)
Inventor
Samuel Dr. Bogoch
Original Assignee
Samuel Dr. Bogoch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samuel Dr. Bogoch filed Critical Samuel Dr. Bogoch
Application granted granted Critical
Publication of ATE8897T1 publication Critical patent/ATE8897T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/473—Recognins, e.g. malignin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
AT80300692T 1979-03-09 1980-03-06 Recognine, ihre chemoreziprokale, am target haftende globuline und verfahren zur herstellung dieser produkte; verfahren zum bestimmen von krebstumoren. ATE8897T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1907879A 1979-03-09 1979-03-09
EP80300692A EP0015755B1 (en) 1979-03-09 1980-03-06 Recognins, their chemoreciprocals, target attaching globulins and processes for producing these products; methods of detecting cancer tumors

Publications (1)

Publication Number Publication Date
ATE8897T1 true ATE8897T1 (de) 1984-08-15

Family

ID=21791299

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80300692T ATE8897T1 (de) 1979-03-09 1980-03-06 Recognine, ihre chemoreziprokale, am target haftende globuline und verfahren zur herstellung dieser produkte; verfahren zum bestimmen von krebstumoren.

Country Status (4)

Country Link
EP (1) EP0015755B1 (https=)
JP (1) JPS55167265A (https=)
AT (1) ATE8897T1 (https=)
DE (1) DE3068844D1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
EP0221748A3 (en) * 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
EP0681480B1 (en) * 1993-03-16 2004-01-07 Samuel Dr. Bogoch Recognin vaccines
JP4901339B2 (ja) * 2006-07-05 2012-03-21 積水メディカル株式会社 細胞に取り込まれた被験化合物の定量方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4830445A (https=) * 1971-08-24 1973-04-21
US4160019A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Detection of cancer associated polypeptide antigen and preparation of antibodies thereto
JPS50103037A (https=) * 1974-01-25 1975-08-14
GB1533464A (en) * 1975-02-18 1978-11-22 Bogoch S Cancer diagnostic agents
GB1524221A (en) * 1975-08-01 1978-09-06 Bogoch S Cancer diagnostic agents
GB1532803A (en) * 1975-10-15 1978-11-22 Bogoch S Cancer diagnostic agents
DE2546670A1 (de) * 1975-10-17 1977-04-21 Samuel Bogoch Recognine
JPS52104649A (en) * 1976-02-28 1977-09-02 Toyoda Gosei Kk Gear with plastic shaft
DE2824917A1 (de) * 1977-07-13 1979-02-01 Corning Glass Works Biologisch aktive konjugate
DE2967534D1 (en) * 1978-07-07 1985-11-28 Bogoch Samuel Product for detecting the presence of cancerous or malignant tumor cells

Also Published As

Publication number Publication date
JPS55167265A (en) 1980-12-26
JPS6362517B2 (https=) 1988-12-02
EP0015755B1 (en) 1984-08-08
EP0015755A2 (en) 1980-09-17
EP0015755A3 (en) 1980-12-10
DE3068844D1 (en) 1984-09-13

Similar Documents

Publication Publication Date Title
Fogg Extracellular products of algae in freshwater
Catsimpoolas et al. Immunochemical study of changes in reserve proteins of germinating soybean seeds
DE2717741C2 (https=)
EP0279862A4 (en) Cytocidal antibody complex and process for its preparation.
ATE24658T1 (de) Verfahren zur herstellung eines molkeproduktes.
EP0221748A3 (en) A process for the production of human antibodies
BG46600A3 (en) Method for preparing derivatives of dihydrobenzofuran and of chromancarboxamides
ATE8897T1 (de) Recognine, ihre chemoreziprokale, am target haftende globuline und verfahren zur herstellung dieser produkte; verfahren zum bestimmen von krebstumoren.
ATE61068T1 (de) Verfahren zur herstellung eines dem menschlichen gamma-interferon aehnlichen polypeptids.
DE69533464D1 (de) Verfahren zur Herstellung von rekombinanten menschlichen LH-RH Rezeptor Proteinen in spezifischen CHO Zellinien.
BG38489A3 (en) Method for preparing oxazophosphorine- 6, 4- thiolcalsulphonic acids and their neutral salts
ES8206855A1 (es) Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas.
WO1997024618A1 (de) Verfahren zur markierung von biomolekülen mit meerrettichperoxidase
CH661735A5 (de) Fragment von menschlichem nebenschilddruesenhormon-peptid.
Pavlik et al. Partial reinforcement effects in a runway: Between-and within-Ss
Estrada-Parra et al. Reaction of adenine-specific antibodies with denatured deoxyribonucleic acid
PT73814A (fr) Procede pour la preparation de nouveaux hexapeptides
Knüfermann et al. Peptide cleavage in sheep erythrocyte membranes during the action of complement
GB1524221A (en) Cancer diagnostic agents
ATE1778T1 (de) Verfahren zur herstellung von r.s. 5-phydroxyphenyl-2,4-imidazolidindion oder r.s. 5-p- hydroxyphenylhydantoin.
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
Tozer et al. Dissociation of serological complexes of ovalbumin and haemoglobin using aqueous carbon dioxide
Nissinen et al. Distribution of histamine in developing rat tissues
SU605608A1 (ru) Способ исследовани ветвей магистральных кровеносных сосудов
SU493710A1 (ru) Способ количественного определени гексозаминов